Selvas Healthcare

셀바스헬스케어 · 208370

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$61M (₩84.2B)

Overview

Selvas Healthcare makes two types of products: medical diagnostic devices, including body-composition analysers that measure muscle, fat, and water by passing a small electrical current through the body, and fully automatic blood-pressure monitors, and assistive-technology devices for people with visual impairments, such as braille notetakers and screen-magnification readers.

Its diagnostic devices are used in healthcare and fitness settings, while its assistive devices serve blind and low-vision users. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company operates two distinct product divisions under the brands ACCUNIQ and HIMS.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$22.3M
▼ −2.8% YoY
Operating profit · FY2025
−US$117.1K
Turned to loss
Net income · FY2025
US$2.8M
▲ +23.4% YoY

Revenue

  • FY2023US$21.6M
  • FY2024US$23M
  • FY2025US$22.3M

Operating profit

  • FY2023US$2.4M
  • FY2024US$2.4M
  • FY2025−US$117.1K

Net income

  • FY2023US$3.7M
  • FY2024US$2.3M
  • FY2025US$2.8M

Key ratios (FY2025)

ROE
5.5%
Debt/Eq
11.1%
Op. margin
-0.5%
Net margin
12.6%
Rev. YoY
▼ −2.8%

Why it matters

The company supports its international reach through dedicated subsidiaries in the United States and China, alongside domestic and overseas distributor networks.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.